Dr. Susan Phenix holds a PhD in Chemical Engineering from MIT and has over 19 years of industrial experience in pharmaceutical development at Pfizer and Genetics Institute/Wyeth BioPharma.  


She is experienced in the full spectrum of CMC development of a wide variety of protein-based therapeutics, including recombinant human proteins, novel engineered proteins, Fc fusion products, monoclonal antibodies and biosimilars, and has led large cross-functional, multi-site teams from preclinical through Proof-of-Concept phases of development.


She has also led technical teams engaged in formulation and clinical drug product development for a variety of protein therapeutics, and multi-company CMC teams involving biomaterials drug delivery and medical device development.